GSK's blood cancer drug fails to secure US FDA advisers' support
Reutersarrow_outwardFDA Committee Votes Against GSK Blood Cancer Drug Blenrep
The Wall Street Journalarrow_outwardFDA’s ODAC Votes Against Risk:Benefit Profiles of Belantamab Mafodotin Combos in R/R Myeloma
OncLivearrow_outwardGSK shares fall after blood cancer drug likely headed for U.S. rejection - MSN
MSNarrow_outwardGSK gets red light from FDA cancer committee on Blenrep combos - Proactive Investors
Proactive Investorsarrow_outwardGSK Faces FDA Advisory Committee Setback on Blenrep for Multiple Myeloma - TipRanks
TipRanksarrow_outwardGSK Plc: Confident In Benefit/risk Profile Of Blenrep - Nasdaq
Nasdaqarrow_outwardGSK's blood cancer drug fails to secure US FDA advisers' support | Business Information & News | FE - Westlaw Today
Westlaw Todayarrow_outwardGSK Blood Cancer Drug Blenrep Fails To Win FDA Panel Support - NDTV Profit
NDTV Profitarrow_outwardShingrix Prefilled Syringe Gets FDA Greenlight, According to GSK - Patient Care Online
Patient Care Onlinearrow_outwardFDA Advisory Panel Votes Against Current Dosage of GSK’s Multiple Myeloma Drug Blenrep - geneonline.com
Geneonline.comarrow_outward‘Missed Opportunity’: GSK Failed To Optimize Blenrep Dosage, US FDA Panel Says - insights.citeline.com
Insights.citeline.comarrow_outwardGSK blood cancer drug Blenrep fails to win FDA panel support - Moneyweb
Moneywebarrow_outwardBlenrep misstep? ODAC cites tox, GSK dosing neglect in MM - BioWorld MedTech
BioWorld MedTecharrow_outwardUS FDA rejects GSK's blood cancer drug over safety, limited treatment benefit - India Today
India Todayarrow_outwardFDA Approves New Prefilled Syringe Presentation of GSK’s Shingrix for Shingles Prevention - PharmExec
PharmExecarrow_outwardFDA advisors spurn GSK's Blenrep comeback dreams on safety, trial concerns - Fierce Pharma
Fierce Pharmaarrow_outwardFDA adcomm votes against GSK’s Blenrep in multiple myeloma - Endpoints News
Endpoints Newsarrow_outwardGSK stock falls after FDA panel rejects blood cancer drug Blenrep - Investing.com UK
Investing.com UKarrow_outwardGSK stock falls after FDA panel rejects blood cancer drug Blenrep - Investing.com
Investing.comarrow_outwardFDA advisers say risks of GSK blood cancer drug outweigh benefits in surprise setback - STAT
STATarrow_outwardGSK stock falls as FDA advisors vote against Blenrep (GSK) - Seeking Alpha
Seeking Alphaarrow_outwardGSK's Linerixibat: A Targeted Solution for PBC Pruritus in a High-Growth Niche - AInvest
AInvestarrow_outwardGSK Blood Cancer Drug Blenrep Fails to Win FDA Panel Support - Bloomberg
Bloombergarrow_outwardGSK’s Linerixibat Poised to Address Substantial Unmet Need - GlobeNewswire
GlobeNewswirearrow_outwardFDA advisers vote against combination therapies of GSK's blood cancer drug - TradingView
TradingViewarrow_outwardGSK’s Prefilled Syringe Presentation of SHINGRIX Approved by FDA - Contract Pharma
Contract Pharmaarrow_outwardFDA Approves Prefilled Syringe Presentation of GSK’s Shingrix for Shingles Prevention - Contagion Live
Contagion Livearrow_outwardGSK wins US approval for prefilled syringe version of shingles vaccine - The Pharma Letter
The Pharma Letterarrow_outwardMarket news - investments.halifax.co.uk
Investments.halifax.co.ukarrow_outwardGSK signals 'very limited' layoffs amid drug R&D ramp-up - FirstWord Pharma
FirstWord Pharmaarrow_outwardGSK’s Blenrep DREAMMs Turn Fitful as FDA Questions Comeback in Multiple Myeloma - BioSpace
BioSpacearrow_outwardGSK telegraphs 'very limited number' of job cuts amid R&D investment spree - Fierce Biotech
Fierce Biotecharrow_outwardSee what £10k invested in ailing GSK shares is worth today… - Fool UK
Fool UKarrow_outwardViiV Healthcare extends voluntary licensing agreement with Medicines Patent Pool to enable access to innovative long-acting injectable HIV treatment - GSK
GSKarrow_outwardGSK Community Health Programme - The King's Fund
The King's Fundarrow_outwardGSK to leave 'lasting legacy' in Ulverston as production ends - Nwemail.co.uk
Nwemail.co.ukarrow_outwardEnd of production at GSK's Ulverston site 'a sad day' - BBC
BBCarrow_outwardGSK to slash cost of malaria jab by more than half - The Telegraph
The Telegrapharrow_outwardGSK turns to AI to offset potential US tariff hit - Financial Times
Financial Timesarrow_outwardGSK plc (GSK) ORD GBP0.3125 Share Research & Insight - Hargreaves Lansdown
Hargreaves Lansdownarrow_outwardGSK boss Emma Walmsley’s pay could rise to nearly £22m in three years’ time - The Guardian
The Guardianarrow_outwardOxford and GSK launch £50million immuno-prevention programme to advance novel cancer research - University of Oxford
University of Oxfordarrow_outward
Gsk close
- 2025-07-18 16:00 event
- 43 sourceslanguage
- 200+ ads_click
- 1 week ago schedule